CSM™ BRIDGES CONTINENTS WITH NEW CLINICAL SUPPLIES PARTNER

August 23, 2005

Applied Clinical Trials

Clinical Supplies Management Inc. (CSM) in Fargo, North Dakota has established a cross-continent relationship with leading UK outsource services provider Brecon Pharmaceuticals Ltd.

FARGO – ND – Clinical Supplies Management Inc. (CSM) in Fargo, North Dakota has established a cross-continent relationship with leading UK outsource services provider Brecon Pharmaceuticals Ltd.

This new relationship provides CSM with a "local" supplier for storage and distribution facilities in Europe, as well as access to Brecon's analytical services and extensive QP release expertise when required. The reciprocal nature of the agreement means that Brecon Pharmaceuticals will use CSM as their US-based clinical supplies partner.

Commenting on the new relationship, CSM's President, Gerald Finken, said, "This new agreement with Brecon enhances our European capabilities for multi-national trials. It is important to have local European storage and distribution solutions for our customers and Brecon provides the high standards we require."

Brecon's Director of Clinical Trials Services, Sue Miles, said, "CSM's attention to customer service complements Brecon's own commitment to excellence and I am confident that this partnership will extend Brecon's global reach".

About CSM

CSM is a clinical trial support services company committed to advancing clinical trials for pharmaceutical and biotechnology companies by providing innovative and customized services in the areas of clinical supplies and subject retention and compliance. CSM is the innovator of On-Demand packaging and labeling, which has greatly improved efficiencies in the clinical supplies process and saved time and money for numerous clients.

About Brecon

Brecon Pharmaceuticals provides packaging, storage, and distribution services for clinical trial materials throughout the world. Brecon's team of QPs and on-site analytical laboratory also ensure efficient and timely import and release of clinical trial supplies into the EU.

Related Content:

News